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Background and objective: Half a century ago the prevalence of Sheehan’s syndrome (SS) was 10–20 per
100 000 women. With better obstetric help the prevalence is assumed to have decreased, especially
in developed countries. The aim of this study is to estimate the prevalence of SS in modern times
in Iceland.
Design: We studied the prevalence of SS in 2009 in a nationwide retrospective population-based study.
Methods: All patients with diagnosed SS were identified, and information regarding obstetric care,
clinical presentation and hormonal assays was collected. Correlation was calculated with Kendall’s
tau-b. Significance level: P!0.05.
Results: Eight women were identified with SS; thus, the prevalence of SS in 2009 was 5.1 per 100 000
women. The mean age at delivery and diagnosis was 33.0 and 36.6 respectively, resulting in a
diagnostic delay (DD) of 1–240 months. Four women had low blood pressure during delivery, and five
had massive blood loss (O1000 ml). Six had complicated deliveries. The most common clinical
presentation was failure to lactate and failure to resume menstruation. The patients had three to five
failing pituitary axis. There was no correlation between bleeding at delivery or the number of
hormonal axes affected and DD.
Conclusion: The prevalence of SS in Iceland was higher than we expected in a country with modern
obstetric care. Long DD and incidental diagnosis indicate that women might be lacking correct
diagnosis and treatment, and thus the prevalence of SS is even higher. As SS is easily diagnosed and
treatable, but can be life-threatening if unrecognised, doctors need to be aware of the disease.
European Journal of Endocrinology 164 349–354Introduction
Sheehan’s syndrome (SS) is a pituitary failure occurring
in women after labour (1). Half a century ago, the
prevalence of SS was 10–20 per 100 000 women (2).
With better obstetric help, it is assumed the incidence
and prevalence has decreased, especially in the
developed countries, and has therefore received little
attention in recent years (3). The current incidence and
prevalence of SS in developed countries is thus not well
known. In the underdeveloped countries where home
deliveries are widely practised and obstetric help is
poor, SS is a big health issue. The prevalence of SS in
India is estimated to be 2.7–3.9% among parous women
older than 20 years (4). In an international database
(KIMS database) containing 1034 patients with GH
deficiency (GHD), SS is the cause in 3.1% of the cases,
and in a Spanish cross-sectional study, SS is the
culprit of GHD in 6–10% of the cases (5, 6). It isndocrinologytherefore possible that SS is more common in the
western world than was previously thought. The aim of
this study is to estimate the prevalence of SS in modern
times in Iceland.Materials and methods
Patients
This is a retrospective study of the prevalence of SS in
Iceland. The study population (nZ157 300) was
composed of all women in Iceland on 1st of January
2009. The fertility rate in Iceland is 2.11 for the years
1981–2005, and still births per 1000 live births for the
same years are 3.1 (Hagstofa I´slands, hagtolur.
[cited 14th of February 2010]; Available from www.
hagstofa.is). The patients were identified by asking all
practicing endocrinologists in Iceland (nZ9) to provideDOI: 10.1530/EJE-10-1004
Online version via www.eje-online.org
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350 H L Kristjansdottir and others EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011) 164information about their patients with SS. Patients were
further identified through the electronic medical record
system (from 1983) at the Landspitali University
Hospital in Iceland, by scanning for the diagnosis of
hypopituitarism (E23) under the International Classi-
fication of Diseases, 10th edition (ICD-10), where patients
with SS were extracted.
The study protocol was approved by the Natio-
nal Bioethics Committee (ethical licence no:
VSNb2009060004/03.15) and Data Protection
Committee in Iceland.p
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.Data collection, hormonal measurements and
statistical analysis
Data on demographic and obstetric features, mode of
presentation, diagnostic delay (DD), and blood and
radiographic test results were collected. Post-partum
haemorrhage (PPH) was defined as little if !500 ml,
medium if 500–1000 ml and gross if more than
1000 ml had occurred in the first 24 h after delivery.
Transfusion was documented if needed in the first 24 h
after delivery. Hypotension at delivery was defined as
documented systolic blood pressure below 90 mmHg.
Results of hormonal blood values were from the time of
diagnosis. All diagnostic testing was done in a
standardised manner at that time. No attempt was
made to criticise the methods used for investigation of
the patients; values are presented with given reference
values as provided in a respective patient’s medical
record. Information on the results of hormonal
measurements in relation to the menstrual cycle was
not available for any of the women. Synacthen testing
was performed with 250 mg Synacthen, and in the
insulin tolerance tests, an injection of Actrapid 0.1 U/kg
was given intravenously according to the clinical
guidelines.
A professional statistician was consulted for statistical
analysis. Excel was used for calculating prevalence.
Numerical variables are presented as averages with
the range. Correlation calculations were done with
Kendall’s tau-b, a non-parametric rank test, and results
were considered significant if P!0.05.T
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We found 8 women with confirmed SS, leading to a
prevalence of 5.1 per 100 000 women.
Demographic and obstetric features
One patient was excluded from further investigation as
clinical data was largely missing. She was born in 1928
and gave birth in the 1960s. For seven patients, detailed
histories were available and are referred to as numbers
1–7 (see Table 1). The age range at the time of the
research was 41–55 years, and the women gave birth
between the years 1985 and 2008. The DD was from 1www.eje-online.org
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Landspitali University Hospital (tertiary hospital), two
in smaller hospitals and one in a birth centre.
Four patients had documented low blood pressure. All
seven women had medium to gross blood loss, and six of
them received blood transfusions. Most of these
deliveries were complicated (see Table 1). Patient no. 1
had an acute Caesarean section (C-section) and medium
blood loss. Patient no. 2 had an acute C-section and
gross blood loss. Patient no. 3 had a vaginal delivery,
inversion of the uterus and gross blood loss. Patient no.
4 had a vaginal delivery that resulted in rupture of the
cervix and gross blood loss. Patient no. 5 had atonic
bleeding with gross blood loss after vaginal delivery of
twins, and patient no. 6 had a ruptured uterus and an
acute C-section with intra-partum fetal death. Patient
no. 7 had an uncomplicated vaginal delivery with
medium blood loss. A summary of demographic and
obstetric features can be seen in Table 1.m
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.Symptoms and radiographic features
Loss of lactation (nZ6) and failure to resume
menstruation (nZ6) were the most common symp-
toms. All of the women had various unspecific
symptoms such as lethargy, intolerance of cold, heat
flushes, decreased libido, dry skin and mood changes.
Some had diminished genital and axial hair. One patient
conceived again with assistive reproductive technology.
Six of seven patients had partially or completely empty
sella on computed tomography/magnetic resonance
imaging (CT/MRI) though patient no. 7 had a normal
pituitary on MRI that was taken 6 weeks after delivery.T
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The results of serum levels and a review of hormonal
axis are given in Tables 2–4. Patient nos 1, 2 and 5 had
deficiency of all anterior pituitary hormones, and
another four women had failure of two to four of the
five pituitary axes. Patient no. 7 had low prolactin (PRL)
level, and all of the other women had low-normal or
normal PRL levels. As none of the women were able to
lactate after delivery, a relative PRL deficiency was
assumed. Patient no. 6 had received Cabercolinum to
hinder lactation after delivery, and analysis of serum
levels of PRL was not performed. In patient no. 1, serum
IGF1 was low, and she was assumed to have GHD, and
no further testing for GHD was done. Patient no. 2 had
normal cortisol at diagnosis (1988), but due to
persistent symptoms she was repeatedly evaluated for
cortisol deficiency and treated with hydrocortisone due
to low urinary cortisol excretion in 1998
(89 nmol/24 h, reference value 97–330 nmol/24 h).
Patient no. 3 had four pituitary axes affected. Her TSH
axis was first assumed to be normal according to
reference values, but due to her symptoms she was
re-evaluated as having subclinical hypothyroidism, andwww.eje-online.org
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www.eje-online.orgas her clinical response to treatment was undoubtful,
she was assumed to have central hypothyroidism.
Patient no. 4 had two axes affected. Patient no. 7 was
taking levothyroxin (L-T4) before delivery, as most of her
thyroid gland had been removed years earlier because of
colloid cysts, but as she had normal serum levels of free
T4 (fT4) and very low levels of TSH, it was assumed she
had central hypothyrosis as well.
There was no correlation between bleeding at
delivery or number of hormonal axes affected or DD.
Significant correlation (PZ0.042, Kendall’s tau-b
correlation coefficientZ0.767) was seen between
adrenal axis failure and the number of axes affected
but not between adrenal axis failure and bleeding at
delivery or DD. No patient had clinical symptoms of
diabetes insipidus, so the posterior part of the pituitary
was not evaluated further.Discussion
The prevalence of SS in the Icelandic population in
2009 is 5.1 per 100 000 women. This, as expected, is
much lower than results from India but higher than
expected in a developed country with good obstetric
help, indicating that SS should not be ignored in
modern societies (4).
Our study is a nationwide population-based study in
a well-defined population. Few endocrinologists
(altogether nine) are responsible for treatment of adult
patients in Iceland, and there is only one University
Hospital. The most advanced obstetric department in
the country is at this hospital as well as the only
Department of Endocrinology. Furthermore, Iceland has
a complete birth registry since 1972 and a complete
national registry since 1914 (Hagstofa I´slands, hagto-
lur. [cited 14th of February 2010]; Available from www.
hagstofa.is, Landlæknir. [cited 1st of May 2010];
Available from www.landlaeknir.is/Heilbrigdistolfraedi/
Gagnasofn/Faedingraskra). We therefore believe the
study is a reliable source of descriptive data on patients
with SS as well as representative of the prevalence of SS
in western countries with modern obstetric help. For the
sake of comparison, the population in our study was
defined as all women alive, as Dr Sheehan did in his
publication, which has often been cited (2).
We found great variation in DD, from 1 month
to 20 years, which is in line with the few published data
(4, 7–9). The patient with the longest DD was inci-
dentally diagnosed (no. 3) even though she was found to
have four pituitary axes affected. This indicates that
women with SS might be lacking correct diagnosis and
treatment. Thus, the prevalence of SS in western countries
may be even higher than presented in this study.
We did not find a correlation between DD and
bleeding at delivery or the number of hormonal axes
affected. PPH and/or hypotension causing pituitary
necrosis have been thought to be the main cause of SS,
Table 4 Results on further evaluation of hormonal axis with insulin tolerance test and Synacthen test.
Insulin tolerance test Synacthen test
Glucose (mmol/l) Cortisol (nmol/l) GH Cortisol (nmol/l)
Patient BV LV BV HV BV HV BV 30 min 60 min
1 – – – – – – 6 20 20
2 (1988/1990)a 5/4.3 2.3/2.0 577/385 658/577 0.6/0.6 mg/l 0.1/!0.1 532 525 660
3 5.3 1.4 508 796 1.5 mUI/l 5.1 – – –
4 4.2 1.4 181 540 0.94 mg/l 2.27 320 671 719
5b 4.8 1.7 32 77 0.2 mUI/l 0.4 – – –
6 3.8 1.6 220 224 0.03 mg/l 0.04 – – –
7 3.7 1.5 !1 2 1.3 mUI/l 21 0.1 20 29
BV, basal value; LV, lowest value; HV, highest value.
aTest performed in the year 1988 and 1990 respectively. Synachten test performed in 1988 on this patient.
bPerformed in 2006.
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(1, 10). Five of the women had more than 1000 ml PPH
and would therefore fit Dr Sheehan’s definition well.
Two of the women had less PPH (nos 1 and 7) and
interestingly woman No. 7 had the shortest DD and the
most serious symptoms. She did not have a traumatic
delivery or hypotension during or after the delivery, and
the estimated blood loss was 700 ml. On the other hand,
she had psoriasis diagnosed before pregnancy, indicat-
ing that the cause of her post-partum hypopituitarism
might be autoimmune hypophysitis. As antibodies
against the pituitary are not on the open market, we
have not been able to test this theory. Theoretically,
women with autoimmune diseases might be at higher
risk for post-partum hypopituitarism.
All women in this study failed to resume menstrua-
tion and were not able to lactate, which is in line with
earlier studies (7, 11, 12). Serum levels of PRL were not
measured until the time of diagnosis or 1–240 months
post delivery. Only one patient (no. 7), the one with the
shortest DD (1 month), had low PRL at the time of
diagnosis. It is therefore impossible to interpret the PRL
levels post delivery for the other patients, but as none of
the women could lactate, they are assumed to have had
PRL deficiency. Evaluation of the serum levels of PRL is a
simple and relatively inexpensive method to test for the
cause of failure to lactate, and by responding to these
specific and obvious early symptoms of SS by evaluating
PRL, the DD can be shortened considerably. Failure to
lactate should therefore lead to evaluation of serum PRL
levels and thereby hinder the long DD of SS.
We found a significant correlation between the
number of hormonal axes affected and failure of the
adrenal axis; thus, women with more severe hypopitui-
tarism are more likely to have adrenal axis failure. The
woman with the longest DD, 240 months, did not have
adrenal axis failure, but the one with the shortest DD
(1 month) did and presented with serious symptoms.
Failure of the adrenal axis is of course the most
important complication of SS and the type of hormonal
deficiency most likely to require emergency treatment
as it can be life-threatening. Women with adrenal axisfailure due to SS are thus more likely to be diagnosed
correctly earlier.
We conclude that the prevalence of SS in modern
times, where obstetric help is good, is higher than we
expected – 5.1 per 100 000 women in Iceland. The
variation in DD and incidental diagnosis of SS found in
our study indicates that SS might be underestimated.
We most often found SS after moderate or severe PPH,
but autoimmune hypophysitis is a possible cause of SS
in one of our women with less severe PPH. Women
failing to lactate should be evaluated by measurements
of serum PRL levels. Doctors should be aware of
symptoms of SS as it can be easily diagnosed and
treated, and it causes increased morbidity and can be
life-threatening if unrecognised.Declaration of interest
The authors declare that there is no conflict of interest that could be
perceived as prejudicing the impartiality of the research reported.Funding
This work was funded by the Science Fund of Landspitali University
Hospital.References
1 Sheehan HL. Post-partum necrosis of the anterior pituitary.
Journal of Pathology and Bacteriology 1937 45 189–214. (doi:10.
1002/path.1700450118)
2 Sheehan HL. The frequency of post-partum hypopituitarism.
Journal of Obstetrics and Gynaecology of the British Commonwealth
1965 72 103–111. (doi:10.1111/j.1471-0528.1965.tb01380.x)
3 Keles¸timur F. Sheehan’s syndrome. Pituitary 2003 6 181–188.
(doi:10.1023/B:PITU.0000023425.20854.8e)
4 Zargar AH, Singh B, Laway BA, Masoodi SR, Wani AI & Bashir MI.
Epidemiologic aspects of postpartum pituitary hypofunction
(Sheehan’s syndrome). Fertility and Sterility 2005 84 523–528.
(doi:10.1016/j.fertnstert.2005.02.022)
5 Abs R, Bengtsson BA, Hernberg-Stahl E, Monson JP, Tauber JP,
Wilton P & Wu¨ster C. GH replacement in 1034 growth hormone
deficient hypopituitary adults: demographic and clinical charac-
teristics, dosing and safety. Clinical Endocrinology 1999 50
703–713. (doi:10.1046/j.1365-2265.1999.00695.x)www.eje-online.org
354 H L Kristjansdottir and others EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011) 1646 Regal M, Paramo C, Sierra SM & Garcia-Mayor RV. Prevalence and
incidence of hypopituitarism in an adult Caucasian population in
northwestern Spain. Clinical Endocrinology 2001 55 735–740.
(doi:10.1046/j.1365-2265.2001.01406.x)
7 Dash RJ, Gupta V & Suri S. Sheehan’s syndrome: clinical profile,
pituitary hormone responses and computed sellar tomography.
Australian and New Zealand Journal of Medicine 1993 23 26–31.
(doi:10.1111/j.1445-5994.1993.tb00533.x)
8 De Bellis A, Kelestimur F, Sinisi AA, Ruocco G, Tirelli G,
Battaglia M, Bellastella G, Conzo G, Tanriverdi F, Unluhizarci K,
Bizzarro A & Bellastella A. Anti-hypothalamus and anti-pituitary
antibodies may contribute to perpetuate the hypopituitarism
in patients with Sheehan’s syndrome. European Journal of
Endocrinology 2008 158 147–152. (doi:10.1530/EJE-07-0647)
9 Do¨kmetas HS, Kilicli F, Korkmaz S & Yonem O. Characteristic
features of 20 patients with Sheehan’s syndrome. Gynecologicalwww.eje-online.orgEndocrinology 2006 22 279–283. (doi:10.1080/09513590600
630504)
10 Sheehan HL. The recognition of chronic hypopituitarism resulting
from postpartum pituitary necrosis. American Journal of Obstetrics
and Gynecology 1971 111 852–854.
11 Haddock L, Vega LA, Aguilo F & Rodriguez O. Adrenocortical,
thyroidal and human growth hormone reserve in Sheehan’s
syndrome. Johns Hopkins Medical Journal 1972 131 80–99.
12 Shahmanesh M, Ali Z, Pourmand M & Nourmand I. Pituitary
function tests in Sheehan’s syndrome. Clinical Endocrinology 1980
12 303–311. (doi:10.1111/j.1365-2265.1980.tb02714.x)
Received 16 December 2010
Accepted 22 December 2010
